| Authors: |
Kim NH; Division of Pulmonary, Critical Care and Sleep Medicine, University of California San Diego, La Jolla, CA., Perez VJ; Stanford University, Stanford, CA., Kingrey J; Baptist Medical Center, Oklahoma City, OK., David Hardy W; Keck School of Medicine of the University of Southern California (USC), Los Angeles, CA., Ryan JJ; University of Utah, Salt Lake City, UT., Tan G; Putnam, Boston, MA., Lopez D; Actelion Pharmaceuticals US, Inc., a Johnson & Johnson company, San Francisco, CA., Adhia A; Actelion Pharmaceuticals US, Inc., a Johnson & Johnson company, San Francisco, CA., Gearhart N; Actelion Pharmaceuticals US, Inc., a Johnson & Johnson company, San Francisco, CA., Lam J; Actelion Pharmaceuticals US, Inc., a Johnson & Johnson company, San Francisco, CA., Sandros M; Actelion Pharmaceuticals US, Inc., a Johnson & Johnson company, San Francisco, CA., Cho M; Actelion Pharmaceuticals US, Inc., a Johnson & Johnson company, San Francisco, CA., Channick R; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA. Electronic address: RChannick@mednet.ucla.edu. |
